--- title: "The Market's Misfit Toys: Crypto Pivots, Nuclear Flops, and Deep-Sea Illusions" type: "News" locale: "en" url: "https://longbridge.com/en/news/293316207.md" description: "From cash-burning deep-sea miners to crypto platforms masquerading as stock brokerages, this residual batch of equities reveals the desperate lengths companies will go to catch a bid in a market dominated by Big Tech." datetime: "2026-07-21T09:13:13.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293316207.md) - [en](https://longbridge.com/en/news/293316207.md) - [zh-HK](https://longbridge.com/zh-HK/news/293316207.md) --- # The Market's Misfit Toys: Crypto Pivots, Nuclear Flops, and Deep-Sea Illusions Welcome to the island of misfit equities. This random assortment of companies that defy neat categorization is essentially a graveyard of pivot attempts, regulatory gambles, and cash-burning pipedreams. In a market where Big Tech sucks the oxygen out of the room, these marginal players are either slapping the "AI" label on their foreheads or digging literal holes in the ocean floor. This is stupid and here's why you should care anyway. ### The Hype Chasers It seems Cameron and Tyler Winklevoss can't stop throwing things at the wall. **Gemini Space Station, Inc. (GEMI.US)** just rolled out commission-free stock trading in July 2026 and snagged a CFTC license for prediction markets. It secured a **USD 100M** strategic investment in Q1, but trying to fight Robinhood in the zero-commission bloodbath seems desperate. When your crypto empire isn't enough to sustain the hype, pivoting to legacy retail mechanics is certainly a choice. Good luck with that. Speaking of misread market enthusiasm, **STANDARD NUCLEAR INC (STDN.US)** tried to ride the nuclear renaissance into a July IPO. The reality check was brutal. They slashed their offering size in half and still tumbled sharply on their debut. Investors might like the idea of advanced TRISO fuel, but they aren't paying a premium for a microscopic **0.5 MTU** production capacity. ### The AI Pretenders and Enablers Everyone wants an AI factory now, even the pharma dinosaurs. **BRISTOL-MYERS SQUIBB CO (BMY.US)** made a splash announcing it's buying Nvidia's newest Vera Rubin systems to build a "powerful AI factory" for drug discovery. They dropped **USD 3.16M** on lobbying in Q2 2026 alone, but lobbying doesn't code AI models. Are you a biotech firm or a server farm? Let's see if this actually produces drugs or just a temporary stock bump. On the flip side, **BANDWIDTH INC (BAND.US)** is actually seeing tangible demand from AI voice technology. They just launched an autonomous AI agent platform, and Citizens bumped their target to **USD 86** on July 20, citing imminent profitability. Meanwhile, **QUANTUM CORPORATION (QMCO.US)** is playing games with its homework. Despite claiming FQ4 2026 revenue of **USD 78M**—up **27%** year-over-year—they delayed their annual report filing, citing "complex balance sheet transactions." Why aren't you moving faster to clean up your books? Huge red flag. ### The Grinders and the Desperate Then we have the companies quite literally drowning in their own ambition. **TMC THE METALS CO INC (TMC.US)** keeps racking up regulatory wins for its deep-sea mining operations, but the stock keeps plunging to new lows. Cash is king, and a drained balance sheet makes regulatory compliance totally irrelevant. **WEBUY GLOBAL LTD (WBUY.US)**, a Singapore-based e-commerce penny stock, is playing the survival game. After narrowly escaping delisting, it’s now hyping AI-assisted travel cards and pointing to a microscopic **USD 907K** Q2 2026 GMV for its Chinese travel platform. Over in the plastics sector, **TEXXON HOLDING LTD (NPT.US)** is facing an uglier reality, reporting a massive **35.8%** revenue drop for the first half of FY2026. No AI buzzwords can fix a broken supply chain. If you want actual money, look at the boring giants. **ICICI BANK LTD (IBN.US)** quietly posted **USD 1.6B** in net profit for its recent quarter. **HUMANA INC (HUM.US)** raked in **USD 39.6B** in Q1 2026 revenue, stubbornly grinding out margins in Medicare Advantage. It's not sexy, but unlike the rest of this list, it's real. _This article does not constitute investment advice._ ### Related Stocks - [STDN.US](https://longbridge.com/en/quote/STDN.US.md) - [GEMI.US](https://longbridge.com/en/quote/GEMI.US.md) - [QMCO.US](https://longbridge.com/en/quote/QMCO.US.md) - [NPT.US](https://longbridge.com/en/quote/NPT.US.md) - [BMY.US](https://longbridge.com/en/quote/BMY.US.md) - [WBUY.US](https://longbridge.com/en/quote/WBUY.US.md) - [BAND.US](https://longbridge.com/en/quote/BAND.US.md) - [HUM.US](https://longbridge.com/en/quote/HUM.US.md) - [IBN.US](https://longbridge.com/en/quote/IBN.US.md) - [TMC.US](https://longbridge.com/en/quote/TMC.US.md) ## Related News & Research - [Bristol-Myers Squibb Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/294214143.md) - [Israel "Izzy" Englander increased his position in this pharma stock by 780%. Does he know something Wall Street doesn't?](https://longbridge.com/en/news/293842675.md) - [Humana's Strong Quarter Fails To Impress](https://longbridge.com/en/news/294238110.md) - [Aristotle Atlantic Partners LLC Takes $1.13 Million Position in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/293837952.md) - [Moody’s assigns Baa3 rating to ICICI Bank USD senior unsecured notes](https://longbridge.com/en/news/293762507.md)